AmSurg bids for TeamHealth again: 4 things to know

In October, TeamHealth rejected AmSurg’s takeover bid, but the surgery center company has come back with a new offer.

Advertisement

Here are four things to know about AmSurg’s proposal.

1. AmSurg is now offering an additional $4 in cash per TeamHealth share, according to the report.

2. The proposal offers 0.768 AmSurg shares plus $15.49 in cash for each TeamHealth share. The new offer is valued at $7.6 billion.

3. AmSurg has given TeamHealth until Nov. 3 to engage. If TeamHealth declines to do so, the offer will be withdrawn.

4. “After meeting with the majority of both companies’ shareholders over the past two weeks, it is clear that they are supportive of the proposed merger and agree that the time to move forward with this combination is now,” said AmSurg president and CEO Christopher Holden. “We hope the TeamHealth board will give this bold opportunity the serious consideration it deserves and will take into account input from TeamHealth shareholders. We look forward to engaging with the TeamHealth board promptly.”

More articles on transactions and valuation issues:
Should you sell your ASC?
Doctors Hospital of Manteca to open outpatient surgery center: 3 notes
Surgery Partners Q3 earnings expected to be $0.23 per share

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.